MEDBOT-B Shares Surge Over 5% as Global Commercial Installations of Toumai Exceed 200 Units

Stock News

06/29

The stock of MEDBOT-B (02252) has risen more than 5%. As of writing, it is up 4.95% to HK$22.88, with a turnover of HK$26.08 million.

The company has announced a significant milestone. Following the achievement of over 300 global commercial orders for its core product, the Toumai endoscopic surgery robot, the system has now been installed at the 200th commercial site worldwide. This latest installation took place at the prestigious Spanish medical institution, HM Hospitales. All 200 installed units have received formal acceptance reports from the end customers.

Market Leadership Position

According to publicly available market statistics, the Toumai robot has achieved the highest number of new global commercial installations among domestic Chinese products so far this year. Globally, it ranks within the top two for this metric.

Significance of the Milestone

The company stated that surpassing these dual milestones in commercial orders and installations signifies the accelerating maturity of Toumai's global clinical ecosystem, real-world application framework, and remote collaboration network.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1170620072"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1170620072\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1170620072?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-29 10:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170620072","market":"us","top_or_hot":-1,"title":"MEDBOT-B Shares Surge Over 5% as Global Commercial Installations of Toumai Exceed 200 Units","media":"Stock News","content":"<p>The stock of <b>MEDBOT-B</b> (<b>02252</b>) has risen more than 5%. As of writing, it is up 4.95% to HK$22.88, with a turnover of HK$26.08 million.<br><br>\nThe company has announced a significant milestone. Following the achievement of over 300 global commercial orders for its core product, the Toumai endoscopic surgery robot, the system has now been installed at the 200th commercial site worldwide. This latest installation took place at the prestigious Spanish medical institution, HM Hospitales. All 200 installed units have received formal acceptance reports from the end customers.<br><br>\n<b>Market Leadership Position</b><br><br>\nAccording to publicly available market statistics, the Toumai robot has achieved the highest number of new global commercial installations among domestic Chinese products so far this year. Globally, it ranks within the top two for this metric.<br><br>\n<b>Significance of the Milestone</b><br><br>\nThe company stated that surpassing these dual milestones in commercial orders and installations signifies the accelerating maturity of Toumai's global clinical ecosystem, real-world application framework, and remote collaboration network.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MEDBOT-B Shares Surge Over 5% as Global Commercial Installations of Toumai Exceed 200 Units</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMEDBOT-B Shares Surge Over 5% as Global Commercial Installations of Toumai Exceed 200 Units\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-29 10:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The stock of <b>MEDBOT-B</b> (<b>02252</b>) has risen more than 5%. As of writing, it is up 4.95% to HK$22.88, with a turnover of HK$26.08 million.<br><br>\nThe company has announced a significant milestone. Following the achievement of over 300 global commercial orders for its core product, the Toumai endoscopic surgery robot, the system has now been installed at the 200th commercial site worldwide. This latest installation took place at the prestigious Spanish medical institution, HM Hospitales. All 200 installed units have received formal acceptance reports from the end customers.<br><br>\n<b>Market Leadership Position</b><br><br>\nAccording to publicly available market statistics, the Toumai robot has achieved the highest number of new global commercial installations among domestic Chinese products so far this year. Globally, it ranks within the top two for this metric.<br><br>\n<b>Significance of the Milestone</b><br><br>\nThe company stated that surpassing these dual milestones in commercial orders and installations signifies the accelerating maturity of Toumai's global clinical ecosystem, real-world application framework, and remote collaboration network.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1617","symbol_name":"AI医疗","start_time":0,"source_url":"","article_id":"1170620072","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170620072","pubTimestamp":1782699514,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"The stock of MEDBOT-B (02252) has risen more than 5%. As of writing, it is up 4.95% to HK$22.88, with a turnover of HK$26.08 million. The company has announced a significant milestone. Following the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1617":"AI医疗","VXUS":"国际股票ETF-Vanguard","BK4588":"碎股","02252":"微创机器人-B","BK1100":"医疗保健设备","BK4585":"ETF&股票定投概念"},"translate_title":"图迈全球商业安装量突破200台，MEDBOT-B股价飙升逾5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02252":1,"VXUS":1},"content_text":"The stock of MEDBOT-B (02252) has risen more than 5%. As of writing, it is up 4.95% to HK$22.88, with a turnover of HK$26.08 million.\nThe company has announced a significant milestone. Following the achievement of over 300 global commercial orders for its core product, the Toumai endoscopic surgery robot, the system has now been installed at the 200th commercial site worldwide. This latest installation took place at the prestigious Spanish medical institution, HM Hospitales. All 200 installed units have received formal acceptance reports from the end customers.\nMarket Leadership Position\nAccording to publicly available market statistics, the Toumai robot has achieved the highest number of new global commercial installations among domestic Chinese products so far this year. Globally, it ranks within the top two for this metric.\nSignificance of the Milestone\nThe company stated that surpassing these dual milestones in commercial orders and installations signifies the accelerating maturity of Toumai's global clinical ecosystem, real-world application framework, and remote collaboration network.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}